Office of the Registrar or Lobbying of BC

Menus

  • Menus

www.lobbyistsregistrar.bc.ca

  • www.lobbyistsregistrar.bc.ca

Designated Filer menu

  • Registry Search Tools
    • 12-Month Lobbying Activity Search
    • Advanced Registry Search
  • Reporting Tools
    • Recent Registrations
    • Recent Lobbying Activity Reports by Posted Date
    • Government Funding Report
    • Gifts to Public Office Holders Report
    • Listing of All Lobbyists and Senior Officers
    • Listing of Senior Public Officer Holders who are in Lobbying Activity Reports
    • Listing of Organizations Clients and their Direct Interests
  • Lobbying Statistics
    • Active Lobbyists and Registrations by Type
    • Ministries/Provincial Entities in Active Registrations
    • Ministries/Provincial Entities in Lobbying Activity Reports
    • Lobbying Activity Reports by Reporting Period
    • Subject Matter in Active Registrations
    • Subject Matter in Lobbying Activity Reports
    • Intended Outcomes in Active Registrations
    • Intended Outcomes in Lobbying Activity Reports
  • Help
    • LTA Guidance Documents
    • Using the Registry
    • Legislation
    • LTA Frequently Asked Questions
    • Contact Us
  • Sign In

You are here:

  1. Registry Dashboard

 

Subject matter details

Moderna Biopharma Canada Corporation


Registration: 4 of 8 (2024-07-08 to 2024-09-03)

Details Regarding the Identified Subject Matter
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Collaborate and advocate for continued funding of Moderna’s Spikevax Covid-19 Vaccine on publicly funded vaccine programs offered by PHSA and/or other Government and RHA programs.
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
COVID-19, Finances and Budgets, Government Procurement, Health, Hospitals, Science and Technology, Senior Citizens
Communication with the BC Government and its stakeholders to advance a pro-innovation business environment for the life sciences sector. The aim is to foster an environment that encourages the development, trialing and adoption of innovative solutions in the life sciences sector, particularly those that leverage the groundbreaking mRNA technology.
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Advanced Education, Economic Development and Trade, Health, Science and Technology
Ensure that any changes to pharmaceutical and vaccine funding support government reimbursement, which in turn enables choice and access to innovation (including mRNA innovation)
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
Finances and Budgets, Government Procurement, Health, Science and Technology, Senior Citizens
Policy and program recommendations regarding the government's stimulus response measures related to COVID-19 and economic recovery.
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
Advanced Education, COVID-19, Economic Development and Trade, Finances and Budgets, Government Procurement, Health, Hospitals, Science and Technology, Senior Citizens
Recommendations regarding job creation and growth of BC's knowledge-based economy. Business incentives for and/or barriers to investment in BC. Sharing of information on Moderna’s global mRNA research investment platform and opportunities for increased investment in BC.
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Advanced Education, Economic Development and Trade, Health, Science and Technology
Upon availability of new vaccines – seek funding for the establishment of new vaccination programs.
Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
Finances and Budgets, Health, Senior Citizens